Thibault Jonckheere

CEO of ImmunXperts

About

Person
Thing
Cofactor will automatically discover the description of this topic and display it here.

Mentions

Xcell Biosciences Corporation, a provider of novel and disruptive systems for cell therapy development and production which combines rapid primary cell expansion and fine control of cell population mix and phenotype across a range of therapeutically important human cell types, today announced the launch of a Technology Access Program (TAP) and the first TAP partner, Thibault Jonckheere, CEO at ImmunXperts in Gosselies, Belgium.

See also: